$23.37
-0.21-0.89%
At close: -
$23.37
0.000.00%
After Hours: Mar 14, 4:00 PM EDT
NewAmsterdam Pharma Co reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of NewAmsterdam Pharma Co using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
NewAmsterdam Pharma Co (NAMS) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on February 26, 2025 for Q4.
The Actual EPS was $-0.51, which missed the estimate of $0.00.
The Actual Revenue was $8.6M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.